nodes	percent_of_prediction	percent_of_DWPC	metapath
Testolactone—Alopecia—Mechlorethamine—lymphatic system cancer	0.0345	0.0345	CcSEcCtD
Testolactone—Anorexia—Mechlorethamine—lymphatic system cancer	0.0265	0.0265	CcSEcCtD
Testolactone—Alopecia—Teniposide—lymphatic system cancer	0.0255	0.0255	CcSEcCtD
Testolactone—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.0241	0.0241	CcSEcCtD
Testolactone—Alopecia—Fludarabine—lymphatic system cancer	0.0224	0.0224	CcSEcCtD
Testolactone—Oedema—Teniposide—lymphatic system cancer	0.0205	0.0205	CcSEcCtD
Testolactone—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.0205	0.0205	CcSEcCtD
Testolactone—Malaise—Fludarabine—lymphatic system cancer	0.0199	0.0199	CcSEcCtD
Testolactone—Anorexia—Teniposide—lymphatic system cancer	0.0195	0.0195	CcSEcCtD
Testolactone—Discomfort—Fludarabine—lymphatic system cancer	0.0185	0.0185	CcSEcCtD
Testolactone—Oedema—Fludarabine—lymphatic system cancer	0.018	0.018	CcSEcCtD
Testolactone—Decreased appetite—Teniposide—lymphatic system cancer	0.0178	0.0178	CcSEcCtD
Testolactone—Vomiting—Mechlorethamine—lymphatic system cancer	0.0177	0.0177	CcSEcCtD
Testolactone—Anorexia—Fludarabine—lymphatic system cancer	0.0172	0.0172	CcSEcCtD
Testolactone—Feeling abnormal—Teniposide—lymphatic system cancer	0.0169	0.0169	CcSEcCtD
Testolactone—Nausea—Mechlorethamine—lymphatic system cancer	0.0165	0.0165	CcSEcCtD
Testolactone—Alopecia—Bleomycin—lymphatic system cancer	0.0164	0.0164	CcSEcCtD
Testolactone—Glossitis—Methotrexate—lymphatic system cancer	0.0162	0.0162	CcSEcCtD
Testolactone—Erythema—Bleomycin—lymphatic system cancer	0.0162	0.0162	CcSEcCtD
Testolactone—Paraesthesia—Fludarabine—lymphatic system cancer	0.0162	0.0162	CcSEcCtD
Testolactone—Decreased appetite—Fludarabine—lymphatic system cancer	0.0156	0.0156	CcSEcCtD
Testolactone—Pain—Fludarabine—lymphatic system cancer	0.0154	0.0154	CcSEcCtD
Testolactone—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.015	0.015	CcSEcCtD
Testolactone—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0148	0.0148	CcSEcCtD
Testolactone—Malaise—Bleomycin—lymphatic system cancer	0.0146	0.0146	CcSEcCtD
Testolactone—Alopecia—Carmustine—lymphatic system cancer	0.0143	0.0143	CcSEcCtD
Testolactone—Erythema—Carmustine—lymphatic system cancer	0.0141	0.0141	CcSEcCtD
Testolactone—Alopecia—Vincristine—lymphatic system cancer	0.0137	0.0137	CcSEcCtD
Testolactone—Discomfort—Bleomycin—lymphatic system cancer	0.0136	0.0136	CcSEcCtD
Testolactone—Alopecia—Mitoxantrone—lymphatic system cancer	0.0133	0.0133	CcSEcCtD
Testolactone—Oedema—Bleomycin—lymphatic system cancer	0.0132	0.0132	CcSEcCtD
Testolactone—Erythema—Mitoxantrone—lymphatic system cancer	0.0131	0.0131	CcSEcCtD
Testolactone—Vomiting—Teniposide—lymphatic system cancer	0.013	0.013	CcSEcCtD
Testolactone—Anorexia—Bleomycin—lymphatic system cancer	0.0126	0.0126	CcSEcCtD
Testolactone—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.0122	0.0122	CcSEcCtD
Testolactone—Nausea—Teniposide—lymphatic system cancer	0.0122	0.0122	CcSEcCtD
Testolactone—Paraesthesia—Bleomycin—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Testolactone—Malaise—Mitoxantrone—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Testolactone—Oedema—Carmustine—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Testolactone—Decreased appetite—Bleomycin—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Testolactone—Vomiting—Fludarabine—lymphatic system cancer	0.0114	0.0114	CcSEcCtD
Testolactone—Pain—Bleomycin—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Testolactone—Discomfort—Mitoxantrone—lymphatic system cancer	0.011	0.011	CcSEcCtD
Testolactone—Oedema—Vincristine—lymphatic system cancer	0.011	0.011	CcSEcCtD
Testolactone—Anorexia—Carmustine—lymphatic system cancer	0.011	0.011	CcSEcCtD
Testolactone—Feeling abnormal—Bleomycin—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Testolactone—Oedema—Mitoxantrone—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Testolactone—Nausea—Fludarabine—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Testolactone—Anorexia—Vincristine—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Testolactone—Paraesthesia—Carmustine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Testolactone—Anorexia—Mitoxantrone—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Testolactone—Decreased appetite—Carmustine—lymphatic system cancer	0.01	0.01	CcSEcCtD
Testolactone—Paraesthesia—Vincristine—lymphatic system cancer	0.00987	0.00987	CcSEcCtD
Testolactone—Pain—Carmustine—lymphatic system cancer	0.00985	0.00985	CcSEcCtD
Testolactone—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00961	0.00961	CcSEcCtD
Testolactone—Decreased appetite—Vincristine—lymphatic system cancer	0.00956	0.00956	CcSEcCtD
Testolactone—Feeling abnormal—Carmustine—lymphatic system cancer	0.00949	0.00949	CcSEcCtD
Testolactone—Pain—Vincristine—lymphatic system cancer	0.0094	0.0094	CcSEcCtD
Testolactone—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00931	0.00931	CcSEcCtD
Testolactone—Pain—Mitoxantrone—lymphatic system cancer	0.00916	0.00916	CcSEcCtD
Testolactone—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00882	0.00882	CcSEcCtD
Testolactone—Vomiting—Bleomycin—lymphatic system cancer	0.00839	0.00839	CcSEcCtD
Testolactone—Nausea—Bleomycin—lymphatic system cancer	0.00784	0.00784	CcSEcCtD
Testolactone—Vomiting—Carmustine—lymphatic system cancer	0.00732	0.00732	CcSEcCtD
Testolactone—Vomiting—Vincristine—lymphatic system cancer	0.00699	0.00699	CcSEcCtD
Testolactone—Nausea—Carmustine—lymphatic system cancer	0.00684	0.00684	CcSEcCtD
Testolactone—Vomiting—Mitoxantrone—lymphatic system cancer	0.00681	0.00681	CcSEcCtD
Testolactone—Alopecia—Methotrexate—lymphatic system cancer	0.00663	0.00663	CcSEcCtD
Testolactone—Erythema—Methotrexate—lymphatic system cancer	0.00654	0.00654	CcSEcCtD
Testolactone—Nausea—Vincristine—lymphatic system cancer	0.00653	0.00653	CcSEcCtD
Testolactone—Nausea—Mitoxantrone—lymphatic system cancer	0.00636	0.00636	CcSEcCtD
Testolactone—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00606	0.00606	CcSEcCtD
Testolactone—Malaise—Methotrexate—lymphatic system cancer	0.00589	0.00589	CcSEcCtD
Testolactone—Discomfort—Methotrexate—lymphatic system cancer	0.0055	0.0055	CcSEcCtD
Testolactone—Anorexia—Methotrexate—lymphatic system cancer	0.00508	0.00508	CcSEcCtD
Testolactone—Paraesthesia—Methotrexate—lymphatic system cancer	0.00479	0.00479	CcSEcCtD
Testolactone—Decreased appetite—Methotrexate—lymphatic system cancer	0.00464	0.00464	CcSEcCtD
Testolactone—Pain—Methotrexate—lymphatic system cancer	0.00456	0.00456	CcSEcCtD
Testolactone—Feeling abnormal—Methotrexate—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Testolactone—Vomiting—Methotrexate—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Testolactone—Nausea—Methotrexate—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
